Lobbying Activity Report

2179-27742

Organization: MS Canada
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 7955-2179-38
Lobbying Activity date: 2023-06-07
Arranged a meeting: No
Posted date: 2023-07-15

In-house lobbyists who participated in the lobbying activity: Alanah Duffy
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement, Health

Mariana Diacu, Excutive Director
Laboratory & Blood Services, Provincial Health Services Authority Footnote1

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Mitch Moneo, Assistant Deputy Minister
Health

Sorin Pop, Executive Director
Integrated Health Services Planning & Systems, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocating for timely access to approved multiple sclerosis(MS) therapies for people living with MS
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 COVID-19, Cannabis, Finances and Budgets, Health, Non-Profit Organization, Poverty
 
Senior officer who filed this Lobbying Activity Report: Pamela Valentine
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: